Chemoinformaics analysis of gamma-Eudesmol, acetate
| Molecular Weight | 264.409 | nRot | 2 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 9 |
| Exact Molecular Weight | 264.209 | nRing | 2 |
| Solubility: LogS | -3.358 | nHRing | 0 |
| Solubility: LogP | 2.702 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 48.6642 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.517 |
| Synth | 3.84 |
| Natural Product Likeliness | 2.406 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.016 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.448 |
| MDCK | 0.0000235 |
| BBB | 0.932 |
| PPB | 0.754639 |
| VDSS | 1.141 |
| FU | 0.325773 |
| CYP1A2-inh | 0.363 |
| CYP1A2-sub | 0.518 |
| CYP2c19-inh | 0.467 |
| CYP2c19-sub | 0.851 |
| CYP2c9-inh | 0.165 |
| CYP2c9-sub | 0.581 |
| CYP2d6-inh | 0.05 |
| CYP2d6-sub | 0.552 |
| CYP3a4-inh | 0.034 |
| CYP3a4-sub | 0.29 |
| CL | 10.528 |
| T12 | 0.189 |
| hERG | 0.009 |
| Ames | 0.004 |
| ROA | 0.195 |
| SkinSen | 0.749 |
| Carcinogencity | 0.06 |
| EI | 0.927 |
| Respiratory | 0.89 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.760491 |